CryptoPolyTech.com
Crypto, Politics, Tech, Gaming & World News.

Siga's smallpox antiviral Tpoxx misses the mark in another mpox study | CPT PPP Coverage

 | cutline • press clip • news of the day |

Cryptopolytech (CPT) Public Press Pass (PPP)
News of the Day COVERAGE

200000048 – World Newser
•| #World |•| #Online |•| #Media |•| #Outlet |

View more Headlines & Breaking News here, as covered by cryptopolytech.com


Siga's smallpox antiviral Tpoxx misses the mark in another mpox study appeared on www.fiercepharma.com by Zoey Becker.

It’s déjà vu for Siga Technologies and its smallpox antiviral Tpoxx. At an interim analysis of a second mpox trial, the drug again missed the mark on a key measure of disease resolution. | The antiviral didn’t demonstrate efficacy in patients with the clade 2 mpox strain, matching August results in patients with clade 1 mpox.

FEATURED ‘News of the Day’, as reported by public domain newswires.

Related Posts
Find more, like the above, right here on Cryptopolytech.com by following our extensive quiclick links appearing on images or [NEWSer CHEWSer].
View ALL Headlines & Breaking News here.

Source Information (if available)

This article originally appeared on www.fiercepharma.com by Zoey Becker – sharing via newswires in the public domain, repeatedly. News articles have become eerily similar to manufacturer descriptions.

We will happily entertain any content removal requests, simply reach out to us. In the interim, please perform due diligence and place any content you deem “privileged” behind a subscription and/or paywall.

CPT (CryptoPolyTech) PPP (Public Press Pass) Coverage features stories and headlines you may not otherwise see due to the manipulation of mass media.

We compile ‘news of the day’ content in an unbiased manner and contextually classify it to promote the growth of knowledge by sharing it just like Siga's smallpox antiviral Tpoxx misses the mark in another mpox study

First to share? If share image does not populate, please close the share box & re-open or reload page to load the image, Thanks!

You might also like
Leave a comment